Yiwen Chen, Yan Shen, Min Zhang, Jian Wu, Shunliang Gao, Risheng Que, Jun Yu, Xiaofeng Tang, Xueli Bai, Tingbo Liang. "Updated results of the PATH study: Adjuvant therapy with donafenib plus a PD-1 inhibitor for patients with hepatocellular carcinoma at high risk of recurrence after resection.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.571